Physician

Matthew D Epstein, MD

According to 2025 Medicare claims, Matthew Epstein, MD (NPI: 1922000793) practices sleep medicine in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. This provider's primary affiliated billing organization is PRACTICE ASSOCIATES MEDICAL GROUP (NPI: 1427016385; TIN: 202088165) and primary practice location at 07927-1902. Epstein is affiliated with the Atlantic ACO (ACO ID: A1026), participating under the MSSP model.

Epstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,194 traditional Medicare patients, billed 1,755 HCPCS/CPT codes, and received $127,968 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 157 prescription claims across 52 beneficiaries totaling $100,623 in drug costs, led by Armodafinil (Armodafinil). DME data shows 7,645 claims. Open Payments data shows 3 records totaling $68. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $213,586 to $100,623. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $100,576 to $284,252.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,107	3,140	$196,014
2016	934	2,848	$160,781
2017	665	1,750	$97,313
2018	933	2,094	$136,416
2019	1,061	2,031	$124,285
2020	928	1,494	$108,791
2021	1,028	1,879	$143,901
2022	1,287	1,990	$148,230
2023	1,217	1,843	$132,785
2024	1,194	1,755	$127,968

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	80	474	$213,586
2016	98	474	$224,411
2017	85	427	$171,311
2018	108	457	$149,471
2019	148	474	$144,096
2020	297	1,025	$338,865
2021	264	945	$526,893
2022	190	729	$571,538
2023	60	244	$512,218
2024	52	157	$100,623

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,191	2,375	$94,592
2016	1,562	3,652	$130,333
2017	1,844	4,199	$127,298
2018	2,359	5,287	$168,536
2019	2,770	5,942	$187,890
2020	2,923	6,587	$224,083
2021	2,976	6,307	$220,491
2022	3,293	7,357	$219,563
2023	3,348	6,902	$231,295
2024	3,874	7,645	$267,890

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	184	184	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	405	489	$102
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	83	83	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	232	273	$70
95800	Sleep study including heart rate, breathing, and sleep time	558	565	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Armodafinil	Armodafinil	20	720	$859
Gabapentin	Gabapentin	12	732	$207
Zolpidem Tartrate	Zolpidem Tartrate	22	1,260	$155
Clonazepam	Clonazepam	31	1,110	$147

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	326	637	$47,649
E0601	Continuous positive airway pressure (cpap) device	Y	259	1,412	$39,678
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	331	646	$30,413
A7031	Face mask interface, replacement for full face mask, each	N	223	444	$28,996
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	333	657	$22,672

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$68	ZOLL Medical Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew D. Epstein, MD?

Tedicare shows public-source Medicare data for Matthew D. Epstein, MD (NPI 1922000793), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew D. Epstein, MD have ACO affiliation data?

Matthew D. Epstein, MD is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026).

What billing organization is linked to Matthew D. Epstein, MD?

Matthew D. Epstein, MD is linked to PRACTICE ASSOCIATES MEDICAL GROUP (billing NPI 1427016385) in the available physician profile data.

Does Matthew D. Epstein, MD have Open Payments data?

Matthew D. Epstein, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.